Quipt Home Medical Past Earnings Performance
Past criteria checks 0/6
Quipt Home Medical has been growing earnings at an average annual rate of 16.6%, while the Healthcare industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 31.4% per year.
Key information
16.6%
Earnings growth rate
30.4%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | 31.4% |
| Return on equity | -6.3% |
| Net Margin | -2.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
We Like These Underlying Return On Capital Trends At Quipt Home Medical (TSE:QIPT)
Dec 15
Earnings Release: Here's Why Analysts Cut Their Quipt Home Medical Corp. (TSE:QIPT) Price Target To CA$10.95
Aug 17Is Quipt Home Medical (TSE:QIPT) A Risky Investment?
Aug 16Quipt Home Medical Corp.'s (TSE:QIPT) 26% Price Boost Is Out Of Tune With Revenues
Jul 26Returns At Quipt Home Medical (TSE:QIPT) Are On The Way Up
Jul 17Investors Aren't Entirely Convinced By Quipt Home Medical Corp.'s (TSE:QIPT) Revenues
Apr 19Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Feb 17What Is Quipt Home Medical Corp.'s (TSE:QIPT) Share Price Doing?
Sep 25Calculating The Fair Value Of Quipt Home Medical Corp. (TSE:QIPT)
Sep 01We Think Quipt Home Medical's (CVE:QIPT) Robust Earnings Are Conservative
Feb 21Earnings Update: Quipt Home Medical Corp. (CVE:QIPT) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Aug 18Health Check: How Prudently Does Quipt Home Medical (CVE:QIPT) Use Debt?
Jul 13When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?
Jun 08Quipt Home Medical Corp. (CVE:QIPT) Shares Could Be 43% Below Their Intrinsic Value Estimate
Jun 02Does Protech Home Medical (CVE:PTQ) Have A Healthy Balance Sheet?
May 07Protech Home Medical Corp. (CVE:PTQ) Could Be Less Than A Year Away From Profitability
Mar 29Can You Imagine How Elated Protech Home Medical's (CVE:PTQ) Shareholders Feel About Its 331% Share Price Gain?
Feb 22Calculating The Fair Value Of Protech Home Medical Corp. (CVE:PTQ)
Jan 18Revenue & Expenses Breakdown
How Quipt Home Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 246 | -7 | 125 | 0 |
| 30 Jun 24 | 244 | -5 | 123 | 0 |
| 31 Mar 24 | 241 | -4 | 122 | 0 |
| 31 Dec 23 | 236 | -4 | 119 | 0 |
| 30 Sep 23 | 212 | -3 | 109 | 0 |
| 30 Jun 23 | 189 | 0 | 98 | 0 |
| 31 Mar 23 | 164 | 2 | 87 | 0 |
| 31 Dec 22 | 139 | 7 | 75 | 0 |
| 30 Sep 22 | 128 | 5 | 71 | 0 |
| 30 Jun 22 | 118 | 2 | 68 | 0 |
| 31 Mar 22 | 109 | 8 | 63 | 0 |
| 31 Dec 21 | 99 | -10 | 54 | 0 |
| 30 Sep 21 | 94 | -6 | 50 | 0 |
| 30 Jun 21 | 87 | -5 | 42 | 0 |
| 31 Mar 21 | 81 | -14 | 39 | 0 |
| 31 Dec 20 | 79 | 1 | 39 | 0 |
| 30 Sep 20 | 73 | -4 | 39 | 0 |
| 30 Jun 20 | 67 | 0 | 38 | 0 |
| 31 Mar 20 | 62 | -6 | 36 | 0 |
| 31 Dec 19 | 63 | -11 | 38 | 0 |
| 30 Sep 19 | 61 | -7 | 34 | 0 |
| 30 Jun 19 | 57 | -27 | 30 | 0 |
| 31 Mar 19 | 56 | -18 | 29 | 0 |
| 31 Dec 18 | 53 | -20 | 29 | 0 |
| 30 Sep 18 | 55 | -7 | 31 | 0 |
| 30 Jun 18 | 59 | -6 | 41 | 0 |
| 31 Mar 18 | 59 | -7 | 43 | 0 |
| 31 Dec 17 | 61 | -4 | 41 | 0 |
| 30 Sep 17 | 61 | -22 | 41 | 0 |
| 30 Jun 17 | 36 | -16 | 27 | 0 |
| 31 Mar 17 | 45 | -19 | 37 | 0 |
| 31 Dec 16 | 56 | -29 | 51 | 0 |
| 30 Sep 16 | 73 | -28 | 60 | 0 |
| 30 Jun 16 | 105 | -18 | 74 | 0 |
| 31 Mar 16 | 94 | -25 | 64 | 0 |
| 31 Dec 15 | 73 | -16 | 44 | 0 |
| 30 Sep 15 | 54 | -18 | 34 | 0 |
| 30 Jun 15 | 42 | -21 | 26 | 0 |
| 31 Mar 15 | 30 | -7 | 16 | 0 |
| 31 Dec 14 | 25 | -4 | 15 | 0 |
| 30 Sep 14 | 19 | -1 | 11 | 0 |
| 30 Jun 14 | 12 | 0 | 6 | 0 |
| 31 Mar 14 | 7 | -1 | 4 | 0 |
| 31 Dec 13 | 5 | -2 | 3 | 0 |
Quality Earnings: QIPT is currently unprofitable.
Growing Profit Margin: QIPT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: QIPT is unprofitable, but has reduced losses over the past 5 years at a rate of 16.6% per year.
Accelerating Growth: Unable to compare QIPT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: QIPT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.8%).
Return on Equity
High ROE: QIPT has a negative Return on Equity (-6.31%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:08 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Quipt Home Medical Corp. is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Doug Cooper | Beacon Securities Limited |
| William Sutherland | Benchmark Company |